A book titled “The War on Ivermectin: The Drug That Saved Millions and Could End the COVID Pandemic” will be distributed by Simon & Schuster, major publisher, According to MedPage today.
It was written by Dr. Pierre Curie, a Wisconsin-based physician who has pushed for the use of ivermectin to treat COVID-19 since the beginning of the pandemic and got involved in anti-mandate political movements.
Currie claims that media censorship and anti-ivermectin “propaganda” prevented widespread use of the drug for the treatment and prevention of COVID-19.
But, Studies have found that ivermectin has no benefits related to COVID-19.
One recently published study involved a collaboration between hospitals and researchers with the goal of quickly identifying any benefits of ivermectin. It involved 1,800 people who were given ivermectin or a placebo and then tracked to see if their mild or moderate symptoms improved or worsened.
According to the University of Kansas Medical Center, Who was involved in the study:
Researchers found that the average recovery time for those taking ivermectin was 12 days, and for those taking a placebo it was 13 days. There were 10 hospitalizations or deaths in the ivermectin group and nine in the placebo group. But these differences failed to be statistically significant, leading the researchers to conclude that “these results do not support the use of ivermectin in patients with mild to moderate COVID-19.”
Kory’s book will be published by Skyhorse Publishing and will go on sale in February. Simon & Shuster is the distributor for Skyhorse, handling things like warehousing and shipping, according to MedPage Today.
Skyhorse has published books by authors who oppose childhood vaccinations and spread misinformation regarding COVID-19, according to MedPage Today.
A Simon & Shuster representative told MedPage Today that “distribution customers are completely independent third parties, noting that their editorial, marketing, and advertising decisions are made independently of Simon & Schuster, and that it does not pick and choose which titles to distribute.”
“This kind of book can do great harm,” Timothy Caulfield, a professor of health law and science policy at the University of Alberta in Canada, told MedPage Today. “It legitimizes bad science and undermines trust in scientific institutions.”
However, Dr. David Boulware, a University of Minnesota physician involved in the research that found no benefits of ivermectin related to COVID-19, told MedPage Today that, in the words of the publication, “lack of transparency from the federal government and poor data create the opportunity for disinformation and conspiracy theories.” About ivermectin for adhesion.”
Ivermectin was discovered in 1975 and was first used to prevent and treat parasites in animals. But it was eventually approved for use in treating a range of infections in humans, putting it on the World Health Organization’s List of Essential Medicines, and winning a Nobel Prize for its creators.
Ivermectin has a very low cost, and many of its benefits to humans occur in very poor countries.
Dozens of readers responded to this MedPage Today article, Showing the conflicting views regarding ivermectin that have arisen during the COVID-19 pandemic.
Some are concerned by the fact that, with some turning to ivermectin during the pandemic, some prominent media organizations and even the federal government have touted it as a drug for livestock, without mentioning its role in helping humans.
One who responded to such a characterization wrote:
This is the problem that pisses me off: “animal worms.” Why do you insist on calling it that instead of an antiparasitic it has been used on humans with great success. You can interrupt the treatment by calling it what it is, an antiparasitic rather than an antiviral, but calling it a drug not intended for human use is absurd. It actually plays to the point that in order to discredit the treatment it has been widely echoed in the media but let’s stick to the facts: it’s an antiparasitic, and there’s no need to use the word “animal”.
Read more: